Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Change in Receivables (2021 - 2025)

Zymeworks' Change in Receivables history spans 5 years, with the latest figure at -$24.7 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 178.13% to -$24.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$51.2 million, a 240.82% decrease, with the full-year FY2025 number at -$51.2 million, down 240.82% from a year prior.
  • Change in Receivables hit -$24.7 million in Q4 2025 for Zymeworks, down from $26.7 million in the prior quarter.
  • Over the last five years, Change in Receivables for ZYME hit a ceiling of $33.5 million in Q1 2023 and a floor of -$47.8 million in Q4 2023.
  • Historically, Change in Receivables has averaged -$33352.9 across 5 years, with a median of $1.1 million in 2024.
  • The widest YoY moves for Change in Receivables: up 697.92% in 2023, down 11886.09% in 2023.
  • Tracing ZYME's Change in Receivables over 5 years: stood at $10.7 million in 2021, then surged by 149.57% to $26.7 million in 2022, then crashed by 279.2% to -$47.8 million in 2023, then surged by 166.18% to $31.6 million in 2024, then crashed by 178.13% to -$24.7 million in 2025.
  • Business Quant data shows Change in Receivables for ZYME at -$24.7 million in Q4 2025, $26.7 million in Q3 2025, and -$22.0 million in Q2 2025.